Advisory Committee on Drug Dependence (1969) Cannabis. HMSO.
Advisory Council on the Misuse of Drugs (2008) Cannabis: Classification and Public Health. Advisory Council on the Misuse of Drugs.
Ashton, H (1989) Risks of dependence on benzodiazepine drugs: a major problem of long-term treatment. BMJ, 298: 103–4.
Ashton, H (1994) The treatment of benzodiazepine dependence. Addiction, 89: 1535–41.
Associated Press in Kingston (2015) Jamaica decriminalises marijuana. The Guardian, 25 Feb.
Australian Bureau of Statistics (1996) National Health Survey, First Results, Australia, 1995. Australian Bureau of Statistics.
Baumler, A (2001) Modern China and Opium: A Reader. University of Michigan Press.
Berridge, V (2013) Demons: Our Changing Attitudes to Alcohol, Tobacco and Drugs. Oxford University Press.
Bewley-Taylor, DR, Fazey, CSJ (2003) The Mechanics and Dynamics of the UN System for International Drug Control. Forward Thinking On Drugs.
Birnbaum, HG, White, AG, Schiller, M et al (2011) Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Medicine, 12: 657–67.
Booth, M (1996) Opium: A History. Simon & Schuster.
Cappato, M, Davies, C, Cohn-Bendit, DC et al (2002) Proposal for a Recommendation, 23 December 2002: Recommendation on the reform of the conventions on drugs (B5–0541/2002). European Parliament.
Cabinet Office Strategy Unit (2013) Alcohol Misuse: How Much Does it Cost?
Cervantes, G (2015) The Cannabis Encyclopedia. Van Patten Publishing.
Chouvy, PA (2009) Opium: Uncovering the Politics of the Poppy. Tauris, I. B.
Dasgupta, N, Creppage, K, Austin, A et al (2014) Observed transition from opioid analgesic deaths toward heroin. Drug and Alcohol Dependence, 145: 238–41.
Davenport-Hines, R, Treadwell, P (2002) The Pursuit of Oblivion: A Global History of Narcotics. Norton, W. W.
Deitch, R (2003) Hemp: American History Revisited: The Plant with a Divided History. Algora.
European Monitoring Centre for Drugs and Drug Addiction (2009) Annual Report on the State of the Drugs Problem in Europe 2009. EMCDDA.
Farrell, M, Buchbinder, R, Hall, W (2014) Should doctors prescribe cannabinoids?
BMJ, 348: 33–6.
Feiling, T (2009) The Candy Machine: How Cocaine Took Over the World. Penguin.
Fischer, B, Keates, A, Bühringer, G et al (2014) Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world?
Addiction, 109: 177–81.
Freudenberg, N (2014) Lethal But Legal: Corporations, Consumption, and Protecting Public Health. Oxford University Press.
Freynhagen, R, Geisslinger, G, Schug, SA (2013) Opioids for chronic non-cancer pain. BMJ, 346: f2937.
Gallup Organization (2011) Youth Attitudes on Drugs: Analytical Report (Flash Eurobarometer 330). European Commission.
Ghodse, H, Corkery, J, Schifano, F et al (2011) Drug-Related Deaths in the UK: Annual Report 2011. International Centre for Drug Policy, St George's, University of London.
Global Commission on Drug Policy (2011) War on Drugs: Report of the Global Commission on Drug Policy. Global Commission on Drugs.
Gootenberg, P (ed) (1999) Cocaine: Global Histories. Routledge.
Griffiths, P, Evans-Brown, M, Sedefov, R (2013) Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age. Addiction, 108: 1700–3.
Hall, W (2015) What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?
Addiction, 110: 19-35.
Holden, A (2004) Makers and Manners: Politics and Morality in Post-War Britain. Politico.
Karch, SB (2005) A Brief History of Cocaine (2nd edn). Taylor and Francis.
Katz, MH (2010) Long-term opioid treatment of nonmalignant pain: a believer loses his faith. Archives of Internal Medicine, 170: 1422–4.
Latimer, D, Goldberg, J (1981) Flowers in the Blood: The Story of Opium. Franklin Watts.
Lim, SS, Vox, T, Flaxman, AD et al (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380: 2224–60.
LSE Ideas (eds) (2014) Ending the Drugs Wars: Report of the LSE Expert Group on the Economics of Drug Policy. London School of Economics.
Maxwell, JC (2011) The prescription drug epidemic in the Unites States: a perfect storm. Drug and Alcohol Reviews, 30: 264–70.
McCoy, AW (1972) The Politics of Heroin in Southeast Asia. Harper & Row
McCoy, AW (1991) The Politics of Heroin: CIA Complicity in the Global Drug Trade. Lawrence Hill Books.
Meacher, MC (2013) Drug policy reform: legal highs. The Psychiatrist, 37: 249–52.
Miron, JA (2005) The Budgetary Implications of Marijuana Prohibition. University of Harvard.
Mokdad, AH, Marks, JS, Stroup, DF et al (2004) Actual causes of death in the United States, 2000. JAMA, 291: 1238–45.
National Institute for Health and Care Excellence (2004) Guidance on the Use of Zaleplon, Zolpidem and Zopiclone for the Short-Term Management of Insomnia Nice [Technology Appraisal Guidance TA77]. NICE.
National Treatment Agency for Substance Misuse (2006) Models of Care for Treatment of Adult Drug Misusers: Update 2006. NTA.
Pew Research Centre (2014) America's New Drug Policy Landscape. Pew Research Centre.
Pudney, S (2003) The Road to Ruin? Sequences of Initiation into Drug Use and Offending by Young People in Britain (Home Office Research Study 253). Home Office Research, Development and Statistics Directorate.
Quah, D, Collins, J, Atuesta Becerra, LH et al (2014) Ending the Drug Wars: Report of the LSE Expert Group on the Economics of Drug Policy. LSE Ideas.
Reuter, P, Crawford, G, Cave, J (1988) Sealing the Borders: The Effects of Increased Military Participation in Drug Interdiction. RAND Corporation.
Reuter, P, Stevens, S (2007) An Analysis of UK Drug Policy: A Monograph Prepared for the UK Drug Policy Commission. UK Drug Policy Commission.
Royal College of Physicians (2001) Alcohol – Can the NHS Afford It?
Senate Special Committee on Illegal Drugs (2002) Cannabis: Our Position for a Canadian Public Policy. Report of the Senate Special Committee on Illegal Drugs. Senate of Canada.
Stannard, C (2013) Opioids in the UK: what's the problem?
BMJ, 347: f5108.
Stockwell, T, Thomas, G (2013) Is Alcohol too Cheap in the UK? The Case for Setting a Minimum Unit Price for Alcohol. Institute of Alcohol Studies.
Sullum, J (2003) Marijuana as a ‘gateway’ drug. Reason, 24 Jan.
United Nations Office on Drugs and Crime (2007) A century of international drug control. Bulletin on Narcotics, LIX (1 and 2): 1-167. Republished 2009. UNODC.
United Nations Office on Drugs and Crime (2009) World Drug Report 2009. UNODC.
United Nations Office on Drugs and Crime (2013) Fact Sheet on Statistics and Trends of Illicit Drugs. Appended to World Drug Report 2013 (UN Office on Drugs and Crime). UNODC.
Weiss, RD, Potter, JS, Fiellin, DA et al (2011) Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Archives of General Psychiatry, 68: 1238–46.
Wilens, TE, Adler, LA, Adams, J et al (2008) Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. Journal of the American Academy of Child & Adolescent Psychiatry, 47: 21-31.